Brief: Pure Biologics KNF Approves Company's Issue Prospectus For Up To 0.6 Mln Shares
06/11/2020 17:09
Nov 6 (Reuters) - Pure Biologics SA PUR1.WA :
* POLAND'S FIN WATCHDOG KNF APPROVES COMPANY'S ISSUE
PROSPECT FOR
UP TO 0.6 MILLION NEW E SERIES SHARES
* KNF ALSO APPROVES ADMITTING COMPANY'S SHARES TO TRADING ON
WSE
Source text for Eikon: ID:nEM8MnDWta
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects